8-K
filed May 27, 2026, 8:33 AM ET
ticker HOTH
CIK 0001711786
other material
confidence high
sentiment neutral
materiality 0.65
Hoth Therapeutics renames to Rocket One Inc.; ticker changes to RKTO, pivots to space AI chip tech
Hoth Therapeutics, Inc.
- Name change effective May 26, 2026; new ticker RKTO starts trading on Nasdaq May 28, 2026.
- Company holds exclusive rights to nanomagnetic AI chip technology for space and defense applications.
- Chip retains data without power, uses ultra-low energy, and is radiation-tolerant for orbital environments.
- Legacy biotech programs will continue under a wholly owned subsidiary.
- Targets satellite, defense, and AI systems power-constrained orbital economy.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-061252
- form_type
- 8-K
- ticker
- HOTH
- cik
- 0001711786
- company_name
- Hoth Therapeutics, Inc.
- filed_at
- 2026-05-27T12:33:47+00:00
- discovered_at
- 2026-05-27T12:35:01.404678+00:00
- generated_at
- 2026-05-27T12:35:33.262829+00:00
- sec_items
- ["5.03", "8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-061252
- json_url
- https://secwatch.observer/filing/0001213900-26-061252.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-061252.md
- text_url
- https://secwatch.observer/filing/0001213900-26-061252.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1711786/000121390026061252/0001213900-26-061252-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1711786/000121390026061252/ea0292213-8k_rocket.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CPSH
CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share
CPS TECHNOLOGIES CORP/DE/
June 1, 2026, 9:35 AM ET
other_material
Items 1.01, 5.03, 8.01, 9.01
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
FDXF
FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed
FedEx Freight Holding Company, Inc.
June 1, 2026, 6:46 AM ET
other_material
Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
XAIR
Beyond Air receives Nasdaq panel grant for continued listing; must meet bid price rule by July 31, 2026
Beyond Air, Inc.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CTOR
Citius Oncology reports Phase 1 combo data for LYMPHIR in gynecologic cancers; 24% ORR, 33% in endometrial cancer
CITIUS ONCOLOGY, INC.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CSR
Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City
CENTERSPACE
June 1, 2026, 4:30 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
DCOM
Dime Commercial Bancshares name change effective; three executives amend employment agreements
Dime Community Bancshares, Inc. /NY/
June 1, 2026, 4:02 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SYRE
Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030
Spyre Therapeutics, Inc.
June 1, 2026, 4:01 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.